MetaCap

GRAIL Financial Statements

NASDAQ: GRALHealth CareMedical SpecialitiesUSD

140.58+7.97 (+6.01%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

GRAIL revenue and earnings

In fiscal 2025, GRAIL generated $147.2 million in revenue, up 17.2% from fiscal 2024, its 3rd consecutive year of revenue growth. GRAIL reported a net loss of $408.4 million, compared with a loss of $2.03 billion a year earlier. Operating margin was -382.0%.

Diluted earnings per share came in at -$11.11. Over the last 3 fiscal years, GRAL's revenue has grown at a 38.4% compound annual rate.

Summary generated from market data by MetaCap's automated system. Methodology

GRAIL income statement (annual)

GRAIL annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20232023-01-01
Revenue147.17M125.59M93.11M55.55M
Revenue growth (YoY)+17.18%+34.90%+67.61%—
Research & Development195.79M322.38M338.75M329.58M
Selling, General & Admin275.80M367.82M362.56M296.44M
Operating Income-562.16M-2.19B-1.52B-5.44B
Other Income (Expense)27.66M26.80M7.75M1.50M
Pretax Income-534.50M-2.16B-1.51B-5.44B
Income Tax-126.15M-135.36M-41.95M-42.29M
Net Income-408.35M-2.03B-1.47B-5.40B
Net Income growth (YoY)————
EPS (Basic)-11.11-63.54-47.21-173.89
EPS (Diluted)-11.11-63.54-47.21-173.89
Shares Outstanding (Basic)36.75M31.90M31.05M31.05M
Shares Outstanding (Diluted)36.75M31.90M31.05M31.05M
EBITDA-544.15M-2.17B-1.50B-5.43B
Operating Margin-381.98%-1743.03%-1627.61%-9798.18%
Net Margin-277.47%-1613.92%-1574.23%-9719.35%

This table shows 4 annual periods of GRAIL's income statement, from FY 2025 back to FY 2023, across 15 line items including revenue, research & development, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow GRAL's reporting calendar. What is a income statement?

More financial data